Amgen Reports Third Quarter 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/12/2026
- Wall St gains as AI earnings lift tech, inflation data supports rate-hold bets
- Oil prices dip as investors weigh lower demand forecasts against US-Iran talks deadlock
- CoreWeave soars after fifth straight quarter of record revenue, raised guide
- Four key things investors will watch in Nvidia's earnings next week
- Silver could surge to $90 as investment demand takes over, Citi says
- Lumentum Holdings (LITE) Tops Q4 EPS by 28c, Beats on Revenue; Offers Q1 Guidance
- Aurora Cannabis rejects Curaleaf's unsolicited $4-per-share takeover bid
- AbCellera Biologics (ABCL) PT Raised to $30 at Truist on 'best-in-class potential'
- Crude Inventory Rose 17.2 Million Barrels Last Week - EIA
- Wall Street ends down as US-Iran peace optimism fades
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
- After-Hours Movers: SPCX, AMD, ANET, PINS, APPS, UPST, ZETA, BKNG, LCID, CPNG, MTCH
Amgen (AMGN) PT Lowered to $182 at RBC Capital
October 31, 2018 7:00 AM EDTRBC Capital analyst Kennen MacKay lowered the price target on Amgen (NASDAQ: AMGN) to $182.00 (from $193.00) while maintaining a Sector Perform rating.
... MoreAmgen (AMGN) Tops Q3 EPS by 24c, FY Guidance Tops Views
October 30, 2018 4:02 PM EDTAmgen (NASDAQ: AMGN) reported Q3 EPS of $3.69, $0.24 better than the analyst estimate of $3.45. Revenue for the quarter came in at $5.9 billion versus the consensus estimate of $5.77 billion.
GUIDANCE:
Amgen sees FY2018 EPS of $14.00-$14.25, versus the consensus of $14.02. Amgen sees... More
